158 related articles for article (PubMed ID: 9070591)
1. Topiramate monotherapy for partial onset seizures.
Sachdeo RC; Reife RA; Lim P; Pledger G
Epilepsia; 1997 Mar; 38(3):294-300. PubMed ID: 9070591
[TBL] [Abstract][Full Text] [Related]
2. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
Ben-Menachem E
Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
[TBL] [Abstract][Full Text] [Related]
6. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group.
Abou-Khalil B
Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Topiramate YP Study Group.
Ritter F; Glauser TA; Elterman RD; Wyllie E
Epilepsia; 2000; 41(S1):82-5. PubMed ID: 10768307
[TBL] [Abstract][Full Text] [Related]
8. Nonfocal generalized tonic-clonic seizures: response during long-term topiramate treatment. Topiramate YTC/YTCE Study Group.
Montouris GD; Biton V; Rosenfeld WE
Epilepsia; 2000; 41(S1):77-81. PubMed ID: 10768306
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
Faught E
Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954
[TBL] [Abstract][Full Text] [Related]
10. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment.
Rosenfeld WE; Sachdeo RC; Faught RE; Privitera M
Epilepsia; 1997; 38 Suppl 1():S34-6. PubMed ID: 9092957
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
Wang Y; Zhou D; Wang B; Kirchner A; Hopp P; Kerling F; Pauli E; Stefan H
Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
[TBL] [Abstract][Full Text] [Related]
12. Preliminary observations on topiramate in pediatric epilepsies.
Glauser TA
Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
[TBL] [Abstract][Full Text] [Related]
13. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
[TBL] [Abstract][Full Text] [Related]
16. Preliminary open-label experience with topiramate in primary generalized seizures.
Biton V
Epilepsia; 1997; 38 Suppl 1():S42-4. PubMed ID: 9092959
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
Elterman RD; Glauser TA; Wyllie E; Reife R; Wu SC; Pledger G
Neurology; 1999 Apr; 52(7):1338-44. PubMed ID: 10227615
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in older patients with partial-onset seizures: a pilot double-blind, dose-comparison study.
Ramsay RE; Uthman B; Pryor FM; Rowan AJ; Bainbridge J; Spitz M; Sirven JI; Frederick TE
Epilepsia; 2008 Jul; 49(7):1180-5. PubMed ID: 18494791
[TBL] [Abstract][Full Text] [Related]
19. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
[TBL] [Abstract][Full Text] [Related]
20. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
